CSIMarket


Viatris Inc   (VTRS)
Other Ticker:  
 

Viatris Inc

VTRS's Fundamental analysis








Viatris Inc 's sales fell by -1.76 % in I. Quarter 2024 from the same quarter a year ago. Ranking at No. 1427

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -0.32 %

Viatris Inc 's net profit deacreased by -49.31 % in I. Quarter 2024 year on year, to $114 millions.

More on VTRS's Growth


Viatris Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 26.29 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 0.86.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.37.


More on VTRS's Valuation
 
 Total Debt (Millions $) 17,971
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 415,168
 Net Income/Employee (TTM) $ -1,516
 Receivable Turnover (TTM) 4.19
 Tangible Book Value (Per Share $) -7.29

Viatris Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 26.29 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 0.86.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.37.

Viatris Inc Price to Book Ratio is at 0.66 lower than Indusry Avg. of 75.46. and higher than S&P 500 Avg. of 0.01

More on VTRS's Valuation

  Market Capitalization (Millions $) 13,280
  Shares Outstanding (Millions) 1,210
  Employees 37,000
  Revenues (TTM) (Millions $) 15,361
  Net Income (TTM) (Millions $) -56
  Cash Flow (TTM) (Millions $) 505
  Capital Exp. (TTM) (Millions $) -379
  Total Debt (Millions $) 17,971
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ 415,168
  Net Income/Employee(TTM) $ -1,516
  Receivable Turnover Ratio (TTM) 4.19
  Tangible Book Value (Per Share $) -7.29

  Market Capitalization (Millions $) 13,280
  Shares Outstanding (Millions) 1,210
  Employees 37,000
  Revenues (TTM) (Millions $) 15,361
  Net Income (TTM) (Millions $) -56
  Cash Flow (TTM) (Millions $) 505
  Capital Exp. (TTM) (Millions $) -379


    VTRS's Profitability Comparisons
Viatris Inc achieved increase in profitability, due to cost control. Operating Margin grew in I. Quarter 2024 to 5.57 %.

Viatris Inc net profit margin of 3.11 % is currently ranking no. 34 in Major Pharmaceutical Preparations industry, ranking no. 112 in Healthcare sector and number 1485 in S&P 500.





  Ratio
   Capital Ratio (MRQ) 1.67
  Total Debt to Equity (MRQ) 0.9
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) 0.32
  Inventory Turnover Ratio (TTM) 2.45



Viatris Inc achieved increase in profitability, due to cost control. Operating Margin grew in I. Quarter 2024 to 5.57 %.

Viatris Inc net profit margin of 3.11 % is currently ranking no. 34 in Major Pharmaceutical Preparations industry, ranking no. 112 in Healthcare sector and number 1485 in S&P 500.

More on VTRS's Key Ratios





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com